Abstract
Stroke is a major cause of morbidity and mortality. Risk factors for stroke have been determined through prospective epidemiologic study. Control of risk factors has been demonstrated to reduce stroke incidence, either through controlled trials or inferred from observational studies. In the past few years, new approaches to the treatment of established risk factors have been discovered. These include aggressive control of hypertension in diabetes patients, prevention of type 2 diabetes through lifestyle modification, carotid endarterectomy for moderate symptomatic carotid stenosis, encouragement of a high level of physical activity, and control of abdominal obesity and elevated body mass index. In addition, new strategies for stroke prevention have been identified, including encouragement of a diet high in fruits, vegetables, whole grains, and omega-3 fatty acids, the use of vitamins B12, B6, and folic acid in hyperhomocysteinemia, and moderate alcohol consumption. Clinical trial data support the use of hydroxymethyl-coenzyme A inhibitors in patients with coronary artery disease, and ramipril in high-risk patients with coronary artery disease and diabetes, for the primary prevention of stroke. New risk factors for stroke are being investigated, including the role of chronic inflammation and infection, and these may provide future strategies for stroke prevention.
Similar content being viewed by others
References and Recommended Reading
Goldstein LB, Adams R, Becker K, et al.: Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation 2001, 103: 163–182.
National Institute of Neurological Disorders and Stroke rt-PA Acute Stroke Study Group: Tissue plasminogen activator in acute ischemic stroke. N Engl J Med 1995, 333: 1581–1587.
Furlan A, Higashida R, Wechsler L, et al.: Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999, 282: 2003–2011.
Psaty BM, Smith NL, Siscovick DS, et al.: Health outcomes associated with antihypertensive therapies used as first-line agents: a systematic review and meta-analysis. JAMA 1997, 277: 739–745.
SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991, 265: 3255–3264.
Staessen JA, Fagard R, Thijs L, et al.: Randomized, double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension: the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997, 350: 757–764.
Tuomilehto J, Rastenyte D, Birkenhager WH, et al.: Effects of calcium channel blockade in older patients with diabetes and systolic hypertension. N Engl J Med 1999, 340: 677–684.
UK Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998, 317: 703–713.
Curb JD, Pressel SL, Cutler JA, et al.: Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension: Systolic Hypertension in the Elderly Program Cooperative Research Group. JAMA 1996, 276: 1886–1892.
Burchfiel CM, Curb JD, Rodriguez BL, et al.: Glucose intolerance and 22-year stroke incidence: the Honolulu Heart Program. Stroke 1994, 25: 951–957.
Kannel WB, McGee DL: Diabetes and cardiovascular disease: the Framingham Study. JAMA 1979, 241: 2035–2038.
Wolf PA, D’Agostino RB, Belanger AJ, Kannel WB: Probability of stroke: a risk profile from the Framingham Study. Stroke 1991, 22: 312–318.
UK Prospective Diabetes Study Group: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type II diabetes (UKPDS 34). Lancet 1998, 352: 854–865.
Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993, 329: 977–986.
Tuomilehto J, Lindstrom J, Eriksson JG, et al.: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001, 344: 1343–1350.
North American Symptomatic Carotid Endarterectomy Trial Collaborators: Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991, 325: 445–453.
Barnett HJ, Taylor DW, Eliasziw M, et al.: Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. N Engl J Med 1998, 339: 1415–1425.
Barnett HJ, Eliasziw M, Meldrum HE: Prevention of ischemic stroke. BMJ 1999, 318: 1539–1543.
Chassin MR: Appropriate use of carotid endarterectomy. N Engl J Med 1998, 339: 1468–1471.
Perry JR, Szalai JP, Norris JW, for the Canadian Stroke Consortium: Consensus against both endarterectomy and routine screening for asymptomatic carotid artery stenosis. Arch Neurol 1997, 54: 25–28.
Halliday AW, for the Steering Committee and for the Collaborators: The Asymptomatic Carotid Surgery Trial (ACST): rationale and design. Eur J Vasc Surg 1994, 8: 703–710.
Hu FB, Stampfer MJ, Colditz GA, et al.: Physical activity and risk of stroke in women. JAMA 2000, 283: 2961–2967.
Lee IM, Hennekens CH, Berger K, et al.: Exercise and risk of stroke in male physicians. Stroke 1999, 30: 1–6.
Rexrode KM, Hennekens CH, Willett WC, et al.: A prospective study of body mass index, weight change, and risk of stroke in women. JAMA 1997, 277: 1539–1545.
Walker SP, Rimm EB, Ascherio A, et al.: Body size and fat distribution as predictors of stroke among US men. Am J Epidemiol 1996, 144: 1143–1150.
Wassertheil-Smoller S, Fann C, Allman RM, et al.: Relation of low body mass index to death and stroke in the Systolic Hypertension in the Elderly Program. Arch Intern Med 2000, 160: 494–500.
Liu S, Manson JE, Meir JS, et al.: Whole grain consumption and risk of ischemic stroke in women. JAMA 2001, 304: 312.
Joshipura KJ, Ascherio A, Manson JE, et al.: Fruit and vegetable intake in relation to risk of ischemic stroke. JAMA 1999, 282: 1233–1239.
Iso H, Rexrode KM, Stampfer MJ, et al.: Intake of fish and omega-3 fatty acids and risk of stroke in women. JAMA 2001, 285: 304–312.
Yokoyama T, Date C, Kokubo Y, Yoshike N, et al.: Serum vitamin C concentration was inversely associated with subsequent 20-year incidence of stroke in a Japanese rural community. The Shibata study. Stroke 2000, 31: 2287–2294.
Asherio A, Rimm EB, Hernan MA, et al.: Relation of consumption of vitamin E, vitamin C, and carotenoids to risk for stroke among men in the United States. Ann Intern Med 1999, 130: 963–970.
Heart Outcomes Prevention Study Investigators: Vitamin E supplementation and cardiovascular events in high-risk patients. N Engl J Med 2000, 342: 154–160.
Boushey CJ, Beresford SA, Omenn GS, et al.: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 1995, 274: 1049–1057.
Perry IF, Refsum H, Morris RW, et al.: Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995, 346: 1395–1398.
Bostom AG, Rosenberg IH, Silbershatz H, et al.: Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: the Framingham Study. Ann Intern Med 1999, 131: 352–355.
Qizilbash N, Lewington S, Duffy S, et al.: Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts: Prospective Studies Collaboration. Lancet 1995, 346: 1647–1653.
Scandinavian Simvistatin Survival Study Group: Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvistatin Survival Study (4S). Lancet 1994, 344: 1383–1389.
Plehn JF, Davis BR, Sacks FM, et al.: Reduction of stroke incidence after myocardial infarction with pravastatin: The Cholesterol and Recurrent Events (CARE) study. Circulation 1999, 99: 216–223.
White HD, Simes RJ, Anderson NE, et al.: Pravastatin therapy and the risk of stroke. N Engl J Med 2000, 343: 317–326.
Vaughan CJ, Murphy MB, Buckley BM: Statins do more than just lower cholesterol. Lancet 1996, 348: 1079–1082.
Heart Outcomes Prevention Evaluation Study Investigators: Effects of an angiotensin converting enzyme inhibitor ramipril on cardiovascular events in high-risk patients. N Engl J Med 2000, 342: 145–153.
Heart Outcomes Prevention Evaluation Study Investigators: Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 2000, 355: 253–259.
Berger K, Ajani UA, Kase CS, et al.: Light-to-moderate alcohol consumption and the risk of stroke among U.S. male physicians. N Engl J Med 1999, 341: 1557–1564.
Rose G, Day S: The population mean predicts the number of deviant individuals. BMJ 1990, 301: 1031–1034.
Bushnell CD, Goldstein LB: Ischemic stroke: recognizing risks unique to women. Women’s Health Primary Care 1999, 2: 788–804.
Viscoli CM, Brass LM, Kernan WN, et al.: Estrogen after ischemic stroke: effect of estrogen replacement on risk of recurrent stroke and death in the Women’s Estrogen for Stroke Trial (WEST). Presented at the 26th Annual International Stroke Conference. Stroke 2001, 32: 329.
Gillum LA, Mamidipudi SK, Johnston SC: Ischemic stroke risk with oral contraceptives: a meta-analysis. JAMA 2000, 284: 72–78.
Esposito G, Blasi F, Allegra L, et al.: Demonstration of viable Chlamydia pneumonia in atherosclerotic plaques of carotid arteries by reverse transcriptase polymerase chain reaction. Ann Vasc Surg 1999, 13: 421–425.
Fagerberg B, Gnarpe J, Gnarpe H, et al.: Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease: a prospective study in middle-aged to elderly men with treated hypertension. Stroke 1999, 30: 299–305.
Mayr M, Kiechl S, Willeit J, et al.: Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis. Circulation 2000, 102: 833–839.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jeerakathil, T.J., Wolf, P.A. Prevention of strokes. Curr Atheroscler Rep 3, 321–327 (2001). https://doi.org/10.1007/s11883-001-0026-7
Issue Date:
DOI: https://doi.org/10.1007/s11883-001-0026-7